Drug Profile
SIG 1311
Alternative Names: SIG-1311Latest Information Update: 11 Aug 2016
Price :
$50
*
At a glance
- Originator Signum Biosciences
- Developer Signum Dermalogix
- Class Small molecules; Terpenes
- Mechanism of Action G protein-coupled receptor modulators; Signal transduction pathway modulators; Toll-like receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 11 Aug 2016 Discontinued for Atopic dermatitis in USA (Topical)
- 24 Sep 2010 Signum Biosciences receives two SBIR grants from the NIAMS for the development of GPCR modulating agents in Skin disorders.
- 13 Jul 2010 Early research in Atopic dermatitis in USA (Topical)